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Abstract
Background: Patient and public involvement (PPI) in research envisages a relationship built throughout the
lifespan of a research project between academics, clinicians and PPI colleagues in order to inform, plan, execute
and, in due course, disseminate and translate research. To be meaningful, all stakeholders need to actively engage
in this exchange of expertise. However, despite some funders requiring PPI plans to be included in grant
applications, there remains a gap between what is expected and what is delivered.
Main body: As an exemplar, we reflect on how, in the Asthma UK Centre for Applied Research (AUKCAR), we set
out to create a supportive, organised environment with the overarching value of ‘keeping patients at the heart of
everything we do’. The key has been in planning and creating a suitably funded organisational infrastructure with
dedicated PPI researchers along with the development of and expectation to abide by an agreed set of norms and
values. Specifically, expecting AUKCAR PhD students and early career researchers to engage with PPI has
established a working mode that we hope will last. Regular interactions and proactive Patient Leads increase PPI
network cohesion.
Conclusion: With adaptation, the AUKCAR PPI model can be translated to international contexts.
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Background
What is patient and public involvement?
The United Kingdom’s (UK) National Institute for
Health Research (NIHR) was created in 2006 with the
goal of “conducting leading-edge research focused on the
needs of patients and the public”, with significant em-
phasis placed on the requirement to include patient and
public involvement (PPI) in their funding programmes
[1]. The establishment of INVOLVE, a NIHR organisa-
tion dedicated to promoting the inclusion of patient
involvement in research, has enabled researchers to in-
clude PPI in their research [2]. The vision is research
that is carried out ‘with’ or ‘by’ members of the public,
rather than ‘on’ or ‘to’ them. Examples of PPI roles in-
clude membership of a patient advisory group, providing
feedback on patient-facing resources or contributing to
research priorities. This involvement is regarded as es-
sential to ensure that the research is relevant to the pop-
ulation(s) it will impact.
Why include PPI in research?
Involving patients and public members is not a new con-
cept. Prior to the inception of the National Health Ser-
vice, hospitals’ contributory schemes incorporated
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community participation in hospital governance [3].
Growing disillusionment in the 1950s led to health ser-
vice user groups campaigning against poor quality
healthcare – patient groups wanted better diagnosis, bet-
ter treatment and for their voice to be involved in deci-
sions about their condition. They challenged the
viewpoint that clinicians and researchers knew best and
were above reprehension for behaviours that were not
deemed beneficial or acceptable by patients. Serious clin-
ical failings, such as the Bristol Royal Infirmary and
Alder Hey scandals, further strengthened the need to in-
volve patient and public members and place them at the
centre of healthcare [4].
Effective PPI contributes to the production of high
quality research that is relevant and beneficial to pa-
tients, the public and the health service [5]. Increasingly,
PPI is a pre-requisite in funding applications and in eth-
ical reviews. However, there is still a gap between what
is written in funding applications and what is needed to
ensure that PPI is meaningful and patients are empow-
ered to contribute. Concerns have been raised about the
legitimacy of PPI in research, with criticisms of it being
tokenistic and a ‘box-ticking’ exercise [6].
What is stopping PPI from being part of research?
Barriers may be conceptual or practical. Despite com-
mitment to collaborating with patients and the public in
research, there is a lack of understanding from re-
searchers regarding what PPI involves, how to support a
diverse range of lay members, and the difference be-
tween PPI and qualitative research [7]. Traditional views
of PPI in research have placed patients in a consulting
role, where major decisions are made by academics and
clinicians, rather than in a meaningful and engaged dia-
logue, collaborating from the outset and ensuring that
the patient voice is heard throughout the research life-
cycle [8]. Models and guides for involving patients in re-
search exist, but the heterogeneity of research projects
makes it difficult to determine a single ‘best’ approach
[9]. Training is required to introduce researchers to the
concept of involvement, the difference between involve-
ment and participation, and how meaningfully to involve
patient and public members in their projects.
Even researchers wanting to ensure meaningful in-
volvement encounter a number of practical challenges,
including funding, PPI recruitment and time constraints.
The development of grant applications can be lengthy
and involving patients incurs additional costs. Without
funding, lay members may be bearing unacceptable out-
of-pocket expenses. Although there are small bursary
schemes available in England, money to support PPI typ-
ically only arrives after the successful securement of
funding; yet, if lay members are only included when
funding has been secured, the opportunity to contribute
to the vital stage of research design has been missed
(Fig. 1). Importantly, there is no PPI funding for unsuc-
cessful grant applications to compensate lay members
for their time. Similarly, it may be difficult supporting
lay members in the dissemination of results when fund-
ing has stopped at the end of a grant.
From a PPI perspective, patients and the public are
often unaware of opportunities to get involved with re-
search, or are unsure about how to work with academics
and clinicians. Lack of training and support can lead to
uncertainty and anxiety about how to contribute or may
cause concern about feeling overburdened by what is re-
quired [10]. Even though not every patient wants to be
involved in healthcare research, barriers must be re-
moved in order to support those who do [11]. PPI can
be a daunting undertaking, pushing researchers out of
Fig. 1 Project flow and timing of funding
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their comfort zone to collaborate meaningfully with lay
members. Academics and lay members both need sup-
port to fully and meaningfully engage with PPI.
Moving from tokenistic PPI to meaningful
involvement
The Public Involvement Impact Assessment Framework
was developed to measure the impact of PPI on research
[12]. However, measuring impact by evaluating PPI as an
intervention is inadequate as involvement needs to be
thought about as “conversations that support two-way
learning” [13]; therefore, only measuring PPI impact on
research without considering the impact on involved pa-
tients omits half of this equation. This highlights the need
for guidelines that offer advice about objective measure-
ment of meaningful PPI involvement, so that researchers
know if they have incorporated PPI in a sound way.
In 2018, the NIHR, the Chief Scientist’s Office of the
Scottish Government, Health and Care Research Wales
and the Northern Ireland Public Health Agency together
launched the National Standards for Public Involvement
[14]. These standards were the result of a public consult-
ation that garnered over 700 responses. There are six
overarching standards, each with multiple indicators, as
follows:
 Inclusive opportunities
 Working together
 Support and learning
 Communications
 Impact
 Governance
The standards can be used to guide researchers to
meaningfully engage in PPI as well as to highlight areas
for improvement and to measure the impact of PPI re-
search and its research outputs.
PPI at the heart of everything we do: an exemplar
We reflect here on our experience of delivering PPI
within the context of the Asthma UK Centre for Applied
Research (AUKCAR) [15]. AUKCAR is a UK-wide vir-
tual centre bringing together world-leading academics
and internationally respected clinicians to collaborate on
key areas of research to improve the management of
asthma [15]. From inception, AUKCAR’s vision has been
to keep patients and public at the heart of all we do,
aligned with the aims of the charity (and our funder) –
Asthma UK. Due to AUKCAR’s foundational work and
experience, we were one of 10 UK sites chosen to pilot
the workability of the NIHR UK Standards for Public In-
volvement at 5 years after inception [14].
A strong PPI organisational infrastructure
A supportive PPI organisational infrastructure was
planned, itemised as part of the initial AUKCAR budget
and implemented during the formative years of the
Centre. The AUKCAR PPI team has four patients as PPI
Leads (three of whom are grant holders), a designated
senior academic Lead, and a funded research fellow re-
sponsible for co-developing and spreading a common
set of PPI norms, facilitating PPI activities and coordin-
ating the Patient Advisory Group – our volunteer group
of over 100 people impacted by asthma. To ensure long-
term embedding of PPI, grant applications for individual
projects include a budget to contribute to PPI within the
Centre. The hope was that this arrangement would en-
able us to sustain the AUKCAR PPI infrastructure to
support PPI at the pre-funding and dissemination stages
(Fig. 1). Whilst this is realistic in the context of large
trial and programme grants, small grants and PhD fel-
lowships rarely have enough budget to make this a viable
model and on-going infrastructure funding has proved
to be invaluable.
The key role of the PPI research fellow
The PPI research fellow is a single-point of contact for
both researchers and PPI colleagues, developing strong
relationships with lay members, providing consistency,
and cascading down PPI norms and values. All PPI ac-
tivity goes through the research fellow, who oversees the
amount of work sent to individual PPI colleagues, mak-
ing sure no one is overburdened or overlooked.
Researchers contact the PPI research fellow to discuss
their projects and PPI requirements, ideally at planning
stage. Study details and the lay summary are emailed to
all PPI colleagues by the research fellow and PPI col-
leagues chose when, in what and how they want to get
involved, based on interest, skills and availability. AUK-
CAR PPI colleagues are not required to commit to a
specific contribution when joining the Patient Advisory
Group, all levels of involvement are welcome. Involve-
ment opportunities over the last 5 years have included
reviewing funding applications, providing feedback on
patient-facing documents, inputting on website design,
research steering group membership, co-application on
project grants, co-authoring research articles, and pre-
senting at conferences.
Building and strengthening the AUKCAR Patient Advisory
Group
Initially, the Patient Advisory Group was established by
advertising and recruiting lay members from asthma
clinics and existing involvement groups. Three PPI Pa-
tient Leads, known to researchers from existing projects,
joined the team as grant holders from the start, with a
fourth lead emerging naturally from the Patient Advisory
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Group over time. The PPI organisational infrastructure
we developed includes Research Leads, PPI Research
Fellows and Patient Leads to facilitate the sharing of
norms and values, which, over time, increase the
strength and cohesion of the group.
Technology, the web and social media facilitate the
process of network building, enabling members to create
online contacts and stay in touch at virtually no financial
cost. We have increased the accessibility of our docu-
ments for PPI colleagues who have visual impairments,
but we are aware that communicating mostly by email
or phone does exclude some members of the public.
The AUKCAR Patient Advisory Group fosters peer sup-
port between its members (both online and offline),
which has been welcomed by many members, who re-
port that being part of the group had a positive impact
on their lives.
Benefits of being part of the AUKCAR PPI community
is discussed by one of our Patient Leads:
“The positive impact for me is it has changed a situ-
ation where asthma was taking everything away, to
one where I can do something productive despite
having asthma and hopefully make a difference for
those with asthma in the future.”
The strength of our Patient Advisory Group increasingly
lies in the links created by Patient Leads. As co-
applicants on AUKCAR’s grants and members of the
Centre Management Committee, they have a good un-
derstanding of the research environment and have pro-
gressively acquired authority within the organisation
through their regular contributions. The confidence that
PPI colleagues increasingly acquire through being mem-
bers of a group gives them a unique and strong voice.
We are witnessing PPI shaping research, even from the
very early stage of co-creating the research questions.
For example, one of AUKCAR’s PhD students is working
on a project that evolved directly from a PPI member’s
suggestion.
PPI and the AUKCAR post-graduate scheme
In addition to collaborating on research projects, PPI
colleagues have a role as educators. They provide know-
ledge about asthma to researchers who have no direct
experience of living with the condition. Successful strat-
egies for enhancing the sharing of expertise have in-
cluded joint training courses and informal discussions
between research and PPI teams.
PPI colleagues have proved invaluable to AUKCAR’s
postgraduate training scheme, which aims to nurture
PhD students to become the next generation of leaders
in world-class asthma research. PPI colleagues are in-
volved in reviewing PhD proposals and candidate
applications, and sit on the interview panels. Integrating
PPI at all stages of research is a requirement in all AUK-
CAR PhD projects. Training in working with PPI col-
leagues and support with facilitating involvement is
provided by the research fellow, free to PhD students,
who inevitably work on a limited research budget. En-
abled by our infrastructure funding, AUKCAR PhD stu-
dents learn first-hand about the benefits of working with
PPI colleagues and integrate descriptions of their PPI
work into their publications and theses. Subsequently,
we have developed a tranche of early career researchers
for whom PPI is the norm.
The value of involving PPI colleagues in AUKCAR’s
Postgraduate training scheme is clear from one student’s
personal experience:
“When I began my PhD, I had little understanding
of PPI, and struggled to see how it was relevant to
my quantitative project. While the support from the
PPI research fellow has been instrumental in facili-
tating work with PPI members, it has been the nu-
merous interactions with the PPI members
themselves that have strengthened my understanding
the most. I feel fortunate to have been part of a re-
search group with an existing Patient Advisory
Group as this allowed me to realise the benefit of
PPI early in my PhD, while it has the greatest poten-
tial to impact my project.”
Both formal and informal training opportunities are
available to PhD students (and to all AUKCAR re-
searchers) such as webinars on PPI-specific topics and
opportunities to pilot research methodologies with PPI
colleagues. We are currently developing training mod-
ules for PPI colleagues to ensure that they are fully sup-
ported in the research environment.
A central role for PPI at the AUKCAR annual scientific
meeting
PPI colleagues have an active role in our Annual Scien-
tific Meeting, including reviewing abstracts, presenting
research, acting as panel members, networking with re-
searchers and judging presentations. The cohesive net-
work, mutual support and familiarity with both the
research and the researchers has enabled PPI colleagues
to actively participate in presentations, involve them-
selves in discussions with other stakeholders and help
with the effective dissemination of AUKCAR research
through media channels [16]. Networking between re-
searchers and PPI colleagues is an essential catalyst of
new and valid research questions and has resulted in the
development of projects that are grounded in the real
world.
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Evaluating our PPI
In 2018, the invitation to be a test-bed site for the six
NIHR UK Standards for Public Involvement in Research
provided us with the opportunity to evaluate the impact
of PPI on AUKCAR research, researchers and lay volun-
teers. Working as a team comprised of academics and
PPI colleagues, we used the six standards to document
the domains where we had achieved meaningful involve-
ment and to identify areas for improvement (Table 1).
Now in our sixth year as AUKCAR, we have incorpo-
rated the standards within our PPI strategy, applying
them to all our work going forward. We have adopted a
pragmatic approach ensuring that individual projects in-
corporate tailored PPI involvement, methods and phil-
osophies, whilst avoiding the pitfall of rigid ‘box ticking’.
What were the lessons learned?
A properly funded supportive organisational infrastruc-
ture is integral to implementing meaningful PPI and re-
ducing unintentional tokenism. This needs to include a
person (a research fellow in our model) able to provide
advice and guidance to researchers, assist in tailoring an
involvement plan to the specific needs of each project,
and (crucially) available throughout the research life-
cycle. Recruiting and involving PPI colleagues is time
consuming and the presence of a dedicated person and
supportive infrastructure minimises the burden for re-
searchers, making consistent PPI (relatively) easy and
thus more likely to happen. An established Patient Ad-
visory Group reduces the time required for PPI recruit-
ment for individual projects and ensures PPI inclusion
in the research design from the pre-funding and dissem-
ination stages.
The collaboration with senior academics is strength-
ened by Patient Leads sitting on the Centre Management
Committee and co-developing the vision and research
strategies of AUKCAR. Patient Leads are mentors to
members of our Patient Advisory Group, leading by ex-
ample, being a contact point for queries, and supporting
and instilling confidence in less experienced members.
Training and support allows our lay members to grow in
their roles and we are increasingly looking to formalise
our PPI training offerings. Communicating effectively
throughout their involvement activities reinforces their
Table 1 Application of NIHR UK Standards for Public Involvement in Research in AUKCAR
UK Standard for Public involvement in
Research
Achievement
Status
Examples of how we achieved this Areas for further improvement
Inclusive opportunities:
Offer public involvement opportunities
that are accessible and that reach people
and groups according to research needs
Achieved The research fellow keeps in touch with the
Patient Advisory Group and advertises
opportunities by email and social media.
We work on a first come first served basis; PPI
colleagues choose what they want to be
involved in, when and how.
Consider sharing information via radio or
through leafleting/advertising in
community spaces
Communications:
Use plain language for well-timed and
relevant communications, as part of in-
volvement plans and activities
Achieved In conjunction with PPI colleagues, we
produced “PPI request forms” for researchers
seeking advice. This ensures requests contain
all information PPI colleagues may want to
know in order to commit to involvement in a
project.
Develop a communication plan for
involvement activities
Support and learning:
Offer and promote support and learning
opportunities that build confidence and
skills for public involvement in research
Partially
achieved
We regularly provide opportunities (e.g.
monthly meetings) for PPI colleagues to learn
and contribute to AUKCAR ongoing research
projects, explaining research methods and their
implementation in lay language, building their
skills and confidence in co-developing the
AUKCAR research.
Provide online training on how to be
involved for researchers and PPI
colleagues. This is currently in
production.
Working together:
Work together in a way that values all
contributions, and that builds and
sustains mutually respectful and
productive relationships
Achieved The AUKCAR PPI strategy was co-produced
with PPI (available on our website).
The quarterly meetings, with the PPI Leads and
PPI Research Fellow, provide opportunities to
collaborate and develop research initiatives.
More training for researchers about PPI
and available AUKCAR support, including
training on ‘soft’ skills such as group
facilitation
Governance:
Involve the public in research
management, regulation, leadership and
decision making
Achieved We have four Patient Leads within AUKCAR
who are grant-holders. and attend Centre Man-
agement Committee meetings
There is a need to identify external
sources of funding to make AUKCAR PPI
sustainable in the long-term.
Impact:
Seek improvement, by identifying and
sharing the difference that public
involvement makes to research
Achieved Projects hold regular meetings with PPI
colleagues to provide update on project status,
gather feedback and show the impact that PPI
contribution has had on the project. We deliver
this in a format of “you said …, we did …”
Potential for annual survey of researchers
and lay members to gather feedback on
PPI.
We will be introducing quarterly
newsletters for larger projects to keep
members regularly engaged
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perceived role as collaborators with power to influence
research decisions. Most importantly, PPI members are
valued colleagues who have a legitimate place at the de-
cision table.
The participation of PPI colleagues is largely through
email and telephone, allowing flexibility around mem-
bers’ individual circumstances. Technology is an add-
itional important enabler. Emails and social media
platforms increasingly allow people to create links that
strengthen the Patient Advisory Group and to easily
maintain contact. PPI colleagues appreciate that the
commitment is flexible, overcoming a barrier they have
found when attempting to join other patient groups.
Global translation – PPI beyond the UK
Having learnt from the development of a successful
model within AUKCAR, we are working together with
researchers in an NIHR Global Health Research Unit on
Respiratory Health (RESPIRE) [17] to adapt this involve-
ment model to different cultural contexts. Similarities
with the AUKCAR model include mandatory inclusion
of PPI plans in RESPIRE projects and a funded PPI re-
search fellow based in the UK providing support and
guidance to RESPIRE researchers to enable the meaning-
ful involvement of patient and community members.
However, we are learning that there are factors that are
not transferable.
PPI in health is a global mandate [18] and its impact
in high-income countries is increasing [19, 20]. Yet, this
is not the case for low- and middle-income countries
(LMIC) where PPI in health research is unusual [21].
There are benefits and challenges to incorporating PPI
in LMICs – PPI can help in the identification and priori-
tisation of research topics to those relevant to end-users,
assist in the practical details of data collection, and help
in the interpretation and implementation of findings in
communities where traditional health practices may be
the norm and health literacy levels may be limited [5].
Barriers to PPI, such as a lack of understanding of the
underlying concept by both researchers and the public,
variations in infrastructure and cultural norms, power
relationships between researchers and the researched,
and resource limitations are the major challenges faced
in developing PPI in LMICs [21]. We are finding it help-
ful to engage with the public as a community rather than
individually and to use alternative terminology such as
‘community engagement and involvement’.
An important aspect of PPI is to address global in-
equity in health research. Equal partnerships and collab-
orations with patients and the public can improve
empowerment, ownership, sustainability and research
capacity in LMICs [22]. This will require the develop-
ment of strategic frameworks to implement the policies
and build the organisational infrastructure needed for
the advancement of PPI in LMICs. To this end, RESPIRE
is funding a research fellowship for a senior colleague to
understand and develop PPI in research in Malaysia and
potentially provide knowledge that can be more widely
applied in LMICs.
Conclusions
Our approach to a PPI organisational infrastructure has
addressed many key PPI challenges, helping to overcome
barriers inherent in a system that relies on project fund-
ing by ensuring that support is available to include PPI
throughout the lifetime of a project, from early ideas to
final dissemination. The provision of a supportive envir-
onment as well as specifically dedicated personnel has
allowed effective sharing and spreading of a common set
of PPI norms and values, with the aim ‘keeping patients
and the public at the heart of everything we do’. Com-
munication technology advances, along with opportun-
ities for face-to-face meetings, have been instrumental in
creating a cohesive Patient Advisory Group. Cultural dif-
ferences between the UK and other countries require
the tailoring of PPI needs to individual country settings
to ensure that research continues to be based on real-life
circumstances and that it positively impacts on the lives
of people living with health conditions worldwide.
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